Ivalue Infosolutions Intrinsic Value
IVALUE • Information Technology
Current Stock Price
₹218.24
Primary Intrinsic Value
₹260.64
Market Cap
₹218.2 Cr
+100.0%
Upside
Median Value
₹436.48
Value Range
₹139 - ₹546
Assessment
Trading Below Calculated Value
Safety Margin
50.0%
IVALUE Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹260.64 | ₹208.51 - ₹312.77 | +19.4% | EPS: ₹21.72, Sector P/E: 12x |
| Book Value Method | asset | ₹462.00 | ₹415.80 - ₹508.20 | +111.7% | Book Value/Share: ₹462.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹436.48 | ₹392.83 - ₹480.13 | +100.0% | Revenue/Share: ₹1336.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹436.48 | ₹392.83 - ₹480.13 | +100.0% | EBITDA: ₹180.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹545.60 | ₹436.48 - ₹654.72 | +150.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹139.01 | ₹125.11 - ₹152.91 | -36.3% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹178.97 | ₹161.07 - ₹196.87 | -18.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹436.48 | ₹392.83 - ₹480.13 | +100.0% | ROE: 26.0%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹475.16 | ₹427.64 - ₹522.68 | +117.7% | EPS: ₹21.72, BVPS: ₹462.00 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
IVALUE Intrinsic Value Analysis
What is the intrinsic value of IVALUE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Ivalue Infosolutions (IVALUE) is ₹436.48 (median value). With the current market price of ₹218.24, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹139.01 to ₹545.60, indicating ₹139.01 - ₹545.60.
Is IVALUE undervalued or overvalued?
Based on our multi-method analysis, Ivalue Infosolutions (IVALUE) appears to be trading below calculated value by approximately 100.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 26.27 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 26.0% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 12.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.15x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Ivalue Infosolutions
Additional stock information and data for IVALUE
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹46 Cr | ₹28 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹66 Cr | ₹66 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹-23 Cr | ₹-23 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹33 Cr | ₹21 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |